Viridian Preparing To Launch Its First Drug And A Fast Follower In TED

FcRn Programs Also Will Yield Phase I Data In 2026

 
• By Mandy Jackson
  
Viridian expects an FDA approval and multiple clinical trial readouts in 2026 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from J.P. Morgan

More from Conferences